Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Cellular Microbiology: Pathogen-Host Cell Molecular Interactions

Rhodococcus equi Virulence-Associated Protein A Is Required for Diversion of Phagosome Biogenesis but Not for Cytotoxicity

Kristine von Bargen, Marco Polidori, Ulrike Becken, Gitta Huth, John F. Prescott, Albert Haas
Kristine von Bargen
1Cell Biology Institute, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Polidori
1Cell Biology Institute, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrike Becken
1Cell Biology Institute, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gitta Huth
1Cell Biology Institute, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Prescott
2Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Haas
1Cell Biology Institute, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: albert.haas@uni-bonn.de
DOI: 10.1128/IAI.00856-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Genetic strategy to create R. equi 103+/ΔvapA. (A) Schematic representation of the creation of R. equi 103+/ΔvapA. Briefly, linearized plasmid pΔvapA was electroporated into 103+ and, after double crossover at the vfb and hfb sites, the entire vapA gene region on the virulence plasmid was replaced by the aacC4 apramycin resistance gene. “VAP” denotes the situation as is found with the relevant section of the virulence-associated plasmid, and ΔvapA describes the situation in the replacement mutant. (B) Agarose gel stained with ethidium bromide. Plasmid DNA isolated from 103+ and from 103+/ΔvapA was used as a template for PCRs with primers to up- and downstream regions of the vapA gene (vapA probes 1 and 2) yielding fragments of 900 bp in the presence of vapA and 1,800 bp in its absence (corresponding to the aacC4 gene with flanking regions of vapA). Primer pair aacC4-F/aacC4-R was used to amplify a fragment of 743 bp in the open reading frame of the apramycin resistance gene with the nucleotide sequence analyzed from pVKT173. A molecular weight marker standard (bp) is shown on the right. (C) The virulence plasmids from 103+ or 103+/ΔvapA were used in PCRs with primers that amplify either the vapA gene as described above or the vapH gene (oligonucleotides vapH-F/-R), which is also located on the VAP. Although vapA is present only in 103+, vapH is present in the wild type and mutant, demonstrating the presence of the VAP in either strain. (D) Immunoblot of R. equi proteins developed with a monoclonal antibody to VapA. Equivalent cell numbers of R. equi overnight cultures were used.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Characterization of R. equi 103+/ΔvapA virulence phenotypes. (A) Multiplication in J774E of 103+, 103−, 103+/ΔvapA, and 103+/ΔvapA complemented with vapA constitutively expressed from hsp60 promoter (103+/ΔvapA Hsp60-VapA). The percentages of infected macrophages with more than 10 bacteria are indicated. Quantitation was done microscopically, based on staining of bacterial DNA with SYTO13. The data represent means and standard deviations from three independent experiments. (B) Same as in panel A, but complementation was done using the endogenous vapA promoter and the vapA gene (103+/ΔvapA endog.VapA). (C) Qualitative determination of phagosome acidification. J774E were infected as in panel A and, after 2 or 24 h, the samples were stained with red LysoTracker and green fluorescent SYTO13. Colocalization between LysoTracker- and green-labeled bacteria was quantified by using confocal laser scanning microscopy. The percentages of phagosomes positive for LysoTracker are indicated. The data shown are the means and standard deviations of three experiments. In panels A, B, and C, at least 50 infected macrophages were analyzed in each experiment per time and sample type. (D) Quantitative determination of average phagosome pH at 3 h of infection (▪). The addition of nigericin collapses pH gradients between phagosome and cytosol and serves as a control for the calibration process in that the pH should be that of the external buffer (∼7.3) after addition (□). Nigericin was added at 3 h of infection (first pH determination), followed by a 20-min incubation period (redetermination of pH [□]).

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Quantification of phagolysosome formation. (A) J774E macrophage lysosomes were preloaded with BSA-rhodamine (BSA-rhod.) and infected with ATTO488-labeled bacteria for 20 min, and the infection was chased for 2 h before fixation. Colocalization of bacteria with the fluorescent tracer was quantified by using confocal laser scanning microscopy. “103+/ΔT”, phagosomes containing bacteria that were heat-killed (15 min, 85°C) before phagocytosis. The data shown are the means and standard deviations of three experiments with at least 50 infected macrophages analyzed per time and sample type. (B) Phagolysosome formation was determined by using a FRET assay. Phagolyososme formation with 103+ was standardized as “1”, and higher indices indicate more fusion. RFU, relative fluorescence units. (C) Representative microscopic fields of the experiments in panel A. Optical overlays are shown with some transmitted light to visualize the cell outlines. Open and closed arrowheads point to phagosomes without and with lysosome colocalization (yellow color due to red-green overlay), respectively.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Cytotoxicity for and survival in macrophages. (A) Cytotoxicity of J774E infection with R. equi, quantified by using a lactate dehydrogenase (LDH) release assay. Cytotoxicity is indicated as the percent of LDH release compared to the LDH release by lysing macrophages with the detergent Triton X-100. Infection was done at an MOI of 30 for 1 h, followed by a 24-h chase. (B) J774E macrophages were infected with 103−, 103+/ΔvapA, or 103+/Δorf8. At 2 and 24 h of infection, macrophages were lysed and plated on nutrient agar. The numbers of CFU were quantified after 30 h of incubation at 30°C and were normalized for the 2-h value corresponding to number of ingested bacteria. The data shown are the means and standard deviations of five independent experiments. (C) J774E macrophages were infected at an MOI of 1 for 30 min and chased for 1.5 or 23.5 h before the addition of medium containing LysoTracker and Syto13 for 30 min, rinsing, and fixation. Macrophages that contained at least one nonphagosomal LysoTracker-positive compartment were counted as positive, and all macrophages devoid of any LysoTracker-positive compartment other than phagosomes were counted as negative. Analysis was done by using confocal laser scanning microscopy, and the data shown are the means and standard deviations of three independent experiments with 50 infected macrophages analyzed for each sample type in each experiment. 103+/ΔvapAc, 103+/ΔvapA complemented with vapA in pSMT3 expressed from its own promoter. (D) Representative micrographs of the experiments quantified in panel C. Size bars, 10 μm. Asterisks mark macrophage nuclei. White arrowheads point to bacteria in macrophages without any LysoTracker-positive compartments, and open arrowheads point to bacteria in macrophages that still stain with LysoTracker.

Tables

  • Figures
  • TABLE 1.

    Oligonucleotide primers used in this study

    PrimerSequence (5′-3′)Restriction sitePositiona
    vapA-pc-1CTAGCTAGCTAGCCGCGAAGGCGATCGAAGGGCNheI12503-12523
    vapA-pc-2CGGGTACCCCTCGCAGCCTGCATGTTTCTGGKpnI13225-13247
    vapA probe-1GCGATCGCAGCCACAGCCGT12576-12595
    vapA probe-2GCGTTGTGCCAGCTACCAGAG13091-13111
    vapA-endo-fw CTAGTCTAGACTAGTGCGTCGCGCAGTACGCCGCXbaI12001-12020
    vapA-endo-rv CCATCGATGGCCTCTTCCTCGACCGTCGTCATCAATCClaI13597-13623
    vapH-FGGACGAGACGAGAGGGGTGC7343-7362
    vapH-RGGATTCGAAAGCAGGTCGAGCG8016-8037
    aacC4-FCGGTGGAGTGCAATGTCGTGCNA
    aacC4-RGCGGATGCAGGAAGATCAACGGNA
    vfB-1GCTCTAGAGGCCGTCGAAGTTGCAAGCGXbaI11924-11943
    vfB-2CGGAATTCCCTTTCGGACGTCGCCCTTCGEcoRI12516-12536
    hfB-1CCCAAGCTTCGCGGTCCAGAAACATGCAGGHindIII13219-13239
    hfB-2CCATCGATGCGCCGGATTGGACGTGCCClaI13787-13805
    • ↵ a Nucleotide positions were taken from the p103 virulence-associated plasmid sequence NC_002576 (20). NA, not applicable.

PreviousNext
Back to top
Download PDF
Citation Tools
Rhodococcus equi Virulence-Associated Protein A Is Required for Diversion of Phagosome Biogenesis but Not for Cytotoxicity
Kristine von Bargen, Marco Polidori, Ulrike Becken, Gitta Huth, John F. Prescott, Albert Haas
Infection and Immunity Nov 2009, 77 (12) 5676-5681; DOI: 10.1128/IAI.00856-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Rhodococcus equi Virulence-Associated Protein A Is Required for Diversion of Phagosome Biogenesis but Not for Cytotoxicity
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rhodococcus equi Virulence-Associated Protein A Is Required for Diversion of Phagosome Biogenesis but Not for Cytotoxicity
Kristine von Bargen, Marco Polidori, Ulrike Becken, Gitta Huth, John F. Prescott, Albert Haas
Infection and Immunity Nov 2009, 77 (12) 5676-5681; DOI: 10.1128/IAI.00856-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
macrophages
phagosomes
Rhodococcus equi
virulence factors

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522